Browse > Article
http://dx.doi.org/10.3347/kjp.2015.53.1.21

Antileishmanial and Cytotoxic Effects of Essential Oil and Methanolic Extract of Myrtus communis L.  

Mahmoudvand, Hossein (Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences)
Ezzatkhah, Fatemeh (Leishmaniasis Research Center, Kerman University of Medical Sciences)
Sharififar, Fariba (Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences)
Sharifi, Iraj (Leishmaniasis Research Center, Kerman University of Medical Sciences)
Dezaki, Ebrahim Saedi (Leishmaniasis Research Center, Kerman University of Medical Sciences)
Publication Information
Parasites, Hosts and Diseases / v.53, no.1, 2015 , pp. 21-27 More about this Journal
Abstract
Plants used for traditional medicine contain a wide range of substances that can be used to treat various diseases such as infectious diseases. The present study was designed to evaluate the antileishmanial effects of the essential oil and methanolic extract of Myrtus communis against Leishmania tropica on an in vitro model. Antileishmanial effects of essential oil and methanolic extract of M. communis on promastigote forms and their cytotoxic activities against J774 cells were evaluated using MTT assay for 72 hr. In addition, their leishmanicidal activity against amastigote forms was determined in a macrophage model, for 72 hr. Findings showed that the main components of essential oil were ${\alpha}$-pinene (24.7%), 1,8-cineole (19.6%), and linalool (12.6%). Findings demonstrated that M. communis, particularly its essential oil, significantly (P<0.05) inhibited the growth rate of promastigote and amastigote forms of L. tropica based on a dose-dependent response. The $IC_{50}$ values for essential oil and methanolic extract was 8.4 and $28.9{\mu}g/ml$ against promastigotes, respectively. These values were 11.6 and $40.8{\mu}g/ml$ against amastigote forms, respectively. Glucantime as control drug also revealed $IC_{50}$ values of 88.3 and $44.6{\mu}g/ml$ for promastigotes and amastigotes of L. tropica, respectively. The in vitro assay demonstrated no significant cytotoxicity in J774 cells. However, essential oil indicated a more cytotoxic effect as compared with the methanolic extract of M. communis. The findings of the present study demonstrated that M. communis might be a natural source for production of a new leishmanicidal agent.
Keywords
Leishmania tropica; cutaneous leishmaniasis; myrtle; promastigote; amastigote; J774-A1 cell;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Shokri A, Sharifi I, Khamesipour A, Nakhaee N, Harandi MF, Nosratabadi J, Hakimi Parizi M, Barati M. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitol Res 2012; 110: 1113-1117.   DOI
2 Ncube NS, Afolayan AJ, Okoh AI. Assessment techniques of antimicrobial properties of natural compounds of plant origin: current methods and future trends. African J Biotechnol 2008; 7: 1797-1806.   DOI
3 Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564-582.
4 Abbaszadeh S, Sharifzadeh A, Shokri H, Khosravi AR, Abbaszadeh A. Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi. J Med Mycol 2014; 24: e51-e56.   DOI
5 de Melo JO, Bitencourt TA, Fachin AL, Cruz EM, de Jesus HC, Alves PB, de Fatima Arrigoni-Blank M, de Castro Franca S, Beleboni RO, Fernandes RP, Blank AF, Scher R. Antidermatophytic and antileishmanial activities of essential oils from Lippia gracilis Schauer genotypes. Acta Trop 2013; 128: 110-115.   DOI
6 Mahboubi M, Kazempour N. The antimicrobial activity of essential oil from Perovskia abrotanoides Karel and its main components. Indian J Pharm Sci 2009; 71: 343-347.   DOI
7 Monzote L, Garcia M, Pastor J, Gil L, Scull R, Maes L, Cos P, Gille L. Essential oil from Chenopodium ambrosioides and main components: activity against Leishmania, their mitochondria and other microorganisms. Exp Parasitol 2014; 136: 20-26.   DOI
8 Sokovic M, van Griensven LJLD. Antimicrobial activity of essential oils and their components against the three major pathogens of the cultivated button mushroom, Agaricus bisporus. Eur J Plant Pathol 2006; 116: 211-224.   DOI
9 Vardar-Unlu G, Candan F, Sokmen A, Daferera D, Polissiou M, Sokmen M, Donmez E, Tepe B. Antibacterial and antioxidant activity of the essential oil and methanol extracts of Thymus pectinatus Fisch. et Mey. var. pectinatus (Lamiaceae). J Agri Food Chem 2003; 51: 63-67.   DOI
10 Sikkema J, de Bont JA, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Mol Biol Rev 1995; 59: 201-222.
11 Cristani M, D'Arrigo M, Mandalari G, Castelli F, Sarpietro MG, Micieli D, Venuti V, Bisignano G, Saija A, Trombetta D. Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem 2007; 55: 6300-6308.   DOI
12 Ismail A, Lamia H, Mohsen H, Samia S, Bassem J. Chemical composition and antifungal activity of three Anacardiaceae species grown in Tunisia. Science Int 2013; 1: 148-154.   DOI
13 Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, Bernardino A, Bourguignon SC, Corte-Real S, Pinho RT, Rodrigues CR, Castro HC. Leishmaniasis treatment-a challenge that remains: a review. Parasitol Res 2008; 103: 1-10.
14 World Health Organization. Control of the leishmaniases. Geneva, Switzerland. WHO Tech Rep Ser 2010; (949): 5-12.
15 Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305-318.   DOI
16 Mahmoudvand H, Sharififar F, Sharifi I, Ezatpour B, Fasihi Harandi M, Makki MS, Zia-Ali N, Jahanbakhsh S. In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, berberine against different Leishmania species. Iranian J Parasitol 2014; 9: 28-36.
17 Rocha LG, Almeida JR, Macedo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine 2005; 12: 514-535.   DOI
18 Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytother Res 2014; 28: 1125-1136.   DOI
19 Hosseinzadeh H, Khoshdel M, Ghorbani M. Antinociceptive, anti-inflammatory effects and acute toxicity of aqueous and ethanolic extracts of Myrtus communis L. aerial parts in mice. J Acupunct Meridian Stud 2011; 4: 242-247.   DOI
20 Tuberoso CIG, Rosa A, Bifulco E, Melis MP, Atzeri A, Pirisi FM, Dessi MA. Chemical composition and antioxidant activities of Myrtus communis L. berries extracts. Food Chem 2010; 123: 1242-1251.   DOI
21 Adams RP. Identification of essential oil components by gas chromatography/mass spectroscopy. Carol Stream, Illinois, USA. Allured Publishing Corporation. 2004.
22 Tumen I, Senol FS, Orhan IE. Inhibitory potential of the leaves and berries of Myrtus communis L. (myrtle) against enzymes linked to neurodegenerative diseases and their antioxidant actions. Int J Food Sci Nutr 2012; 63: 387-392.   DOI
23 Sumbul S, Ahmed MA, Asif M, Akhtar M. Myrtus communis Linn.-a review. Indian J Nat Prod Resour 2011; 2: 395-402.
24 Evans WC. Trease and Evans Pharmacognosy. 14th ed. WB Saunders Company Ltd. 1998, pp. 15-16.
25 Mahmoudvand H, Tavakoli R, Sharififar F, Minaie K, Ezatpour B, Jahanbakhsh S, Sharifi I. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone. Pharm Biol 2014; 4: 1-6.
26 Mahmoudvand H, Shakibaie M, Tavakoli R, Jahanbakhsh S, Sharifi I. In vitro study of leishmanicidal activity of biogenic selenium nanoparticles against Iranian isolate of sensitive and glucan-time-resistant Leishmania tropica. Iran J Parasitol 2014; 9(4): 452-460.
27 Weniger B, Robledo S, Arango GJ, Deharo E, Aragon R, Munoz V, Callapa J, Lobstein A, Anton R. Antiprotozoal activities of Colombian plants. J Ethnopharmacol 2001; 78: 193-200.   DOI
28 Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol 2006; 106: 290-302.   DOI